2011 Q3/Global Life Sciences


Summary

Full results


Changes in rank are compared to 2011 Q2/Global Life Sciences. Since then, 12 sites could not be included in the rankings (2 more since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
+ 1 Cilag AG 8.31
+ 1 Lumavita AG 8.12
- 2 Siegfried AG 8.10
+ 2 Axentis Pharma AG 7.72
+ 3 Medinova AG 7.57
+ 1 Actelion Ltd. 7.46
+ 10 Pharmakon Ltd. 7.22
- 3 Newron 6.95
+ 2 Neurimmune Therapeutics AG 6.94
- 1 4-Antibody AG 6.85
- 1 Nycomed International Management GmbH 6.76
+ 9 BioPartners GmbH 6.68
+ 2 Kuros Biosurgery AG 6.65
- 1 Helvepharm AG 6.64
+ 10 Neurotune 6.59
+ 94 Neurim Pharmaceuticals S.A. 6.50
+ 7 ArisGen SA 6.49
+ 15 Dr. Wild & Co. AG 6.32
+ 36 Evolva SA 6.32
+ 14 Virbac Schweiz AG 6.32
+ 33 Arpida AG 6.32
+ 4 Tricom GmbH, Pharma Division 6.32
same Tillotts Pharma AG 6.30
+ 14 Max Zeller Söhne AG 6.22
+ 5 OMIDA AG 6.22
+ 5 GKL Biotec AG 6.20
+ 15 Acino Holding AG 6.14
- 1 GlaxoSmithKline AG 6.05
- 10 MEDA Pharma GmbH 6.03
- 1 Auris Medical AG 5.97
+ 5 Octapharma AG 5.91
+ 9 Anavex Life Sciences Corp. 5.90
+ 4 Lipideon Biotechnology AG 5.88
- 2 Molecular Partners 5.79
+ 34 Boehringer Ingelheim Schweiz GmbH 5.79
- 16 Pentapharm (DSM Nutritional Products AG) 5.76
+ 2 Biogen Idec International GmbH 5.76
+ 10 Novartis International AG 5.72
+ 1 Johnson & Johnson Pharmaceutical Research & Development 5.70
+ 12 F. Hoffmann-La Roche AG (CH) 5.63
+ 4 Bristol-Myers Squibb SA 5.47
+ 4 BioVersys GmbH 5.45
+ 14 Addex Pharmaceuticals 5.41
+ 3 Debiopharm S.A. 5.38
+ 4 Teva Pharma AG 5.33
+ 4 Novelty Pharma Galenical Development and Documentation 5.31
+ 4 Mundipharma Medical Company 5.30
- 5 A. Menarini AG 5.23
+ 19 Merz Pharma (Schweiz) AG 5.20
+ 11 Galenica Ltd. 5.17
- 39 Vifor (International) Ltd. 5.06
- 8 Sanofi-Aventis 5.03
+ 6 Covagen AG 4.89
+ 2 AstraZeneca 4.89
- 39 F. Hoffmann-La Roche AG (Worldwide) 4.86
+ 4 Lunamed AG 4.83
+ 6 NovImmune 4.80
- 5 Abbott Laboratories 4.76
+ 8 Mepha Pharma AG 4.75
- 32 AmVac AG 4.73
+ 1 Aurora Pharma GmbH 4.71
- 27 Cytos Biotechnology AG 4.67
- 45 Med Discovery S.A. 4.59
+ 2 Ergonex Pharma GmbH 4.58
- 51 Antares Pharma AG 4.57
+ 33 GeNeuro SA 4.40
+ 3 Novo Nordisk Pharma AG 4.40
+ 3 Spirig Pharma AG 4.40
+ 9 Streuli Pharma AG 4.38
+ 15 Medipol SA 4.31
+ 6 Kenta Biotech AG 4.22
- 14 Permamed AG 4.22
- 69 Nycomed Pharma AG 4.14
+ 5 AC Immune SA 4.12
+ 1 GlycoVaxyn AG 4.12
- 4 Ferring International Center SA 4.06
+ 3 Nitec Pharma AG 4.01
+ 5 Multipharma 3.88
+ 5 Merck Serono International SA 3.83
- 16 Solvay Pharma AG 3.76
same mondoBIOTECH AG 3.69
- 8 LEO Pharmaceutical Products Sarath Ltd. 3.69
+ 12 Lundbeck (Schweiz) AG 3.67
- 19 Basilea Pharmaceutica Ltd. 3.63
+ 1 Medena 3.61
+ 4 Crucell | Berna Biotech Ltd 3.58
same Gruenenthal Pharma AG 3.51
+ 9 Allergan AG 3.50
- 1 OM PHARMA 3.44
- 8 CSL Behring AG 3.42
- 2 Novartis Pharma Schweiz AG 3.40
- 19 AstraZeneca AG 3.24
+ 7 PFC Pharma Focus Switzerland 3.16
+ 15 APR Applied Pharma Research s.a. 3.13
+ 1 ESBATECH AG 3.04
+ 8 Cryo-Save AG 3.04
- 4 Redbiotec AG 2.97
+ 4 GenKyoTex SA 2.71
- 8 Galderma Pharma SA 2.68
+ 3 GlaxoSmithKline 2.60
- 3 PharmaSwiss SA - HQ 2.57
+ 3 Schwabe Pharma AG 2.53
- 2 Eli Lilly 2.51
- 10 Johnson & Johnson 2.44
+ 1 Bristol-Myers Squibb 2.32
+ 5 Bayer Schweiz AG 2.17
+ 1 Geistlich Pharma AG 2.16
- 16 Pfizer 2.04
+ 3 Genzyme GmbH 1.91
+ 4 Merck 1.88
- 4 Merck Sharp & Dohme-Chibret AG 1.85
+ 1 Helsinn Healthcare S.A. 1.83
+ 2 Wyeth Pharmaceuticals AG 1.45
+ 2 Pfizer (Switzerland) 1.45
+ 2 Baxter Switzerland 0.54